Nygren Andreas, Thorén Anders, Ricksten Sven-Erik
Department of Cardiothoracic Anaesthesia and Intensive Care, Sahlgrenska University Hospital, Göteborg, Sweden.
Crit Care Med. 2006 Mar;34(3):722-9. doi: 10.1097/01.CCM.0000201879.20281.C6.
To evaluate the potential differential effects of norepinephrine, an alpha1-, beta1-, and beta2-receptor agonist, to the alpha1-agonist phenylephrine on jejunal mucosal perfusion, gastric-arterial PCO2 gradient, and the global splanchnic oxygen demand-supply relationship after cardiac surgery.
A randomized, prospective, interventional crossover study.
A university cardiothoracic intensive care unit.
Ten patients were studied during propofol sedation and mechanical ventilation after uncomplicated coronary artery bypass surgery.
Each patient received randomly and sequentially norepinephrine (0.052+/-0.009 microg/kg/min) and phenylephrine (0.50+/-0.22 microg/kg/min) to increase mean arterial blood pressure by 30%.
Data on jejunal mucosal perfusion, jejunal mucosal hematocrit, and red blood cell velocity (laser Doppler flowmetry) as well as gastric-arterial Pco2 gradient (tonometry) and splanchnic oxygen extraction were obtained before (control) and during a 30-min drug infusion period after the target mean arterial blood pressure was reached. The procedure was sequentially repeated for the second vasopressor. Both drugs induced a 40-46% increase in systemic vascular resistance with no change in cardiac index. Neither jejunal mucosal perfusion, jejunal mucosal hematocrit, red blood cell velocity, nor gastric-arterial Pco2 gradient was affected by any of the vasopressors. Splanchnic oxygen extraction increased from 38.2% to 43.1% (p<.001) with norepinephrine and from 39.3% to 47.5% (p<.001) with phenylephrine. This increase was significantly more pronounced with phenylephrine compared with norepinephrine (p<.05). Mixed venous-hepatic vein oxygen saturation gradient increased with both drugs (p<.01), and the increase was more pronounced with phenylephrine (p<.05). Splanchnic lactate extraction was not significantly affected by any of the vasopressors.
Phenylephrine induced a more pronounced global alpha1-mediated splanchnic vasoconstriction compared with norepinephrine. Neither of the vasoconstrictors impaired perfusion of the gastrointestinal mucosa in postcardiac surgery patients. The lack of norepinephrine-induced, alpha1-mediated impairment of gastrointestinal perfusion is not explained by a beta2-mediated counteractive vasodilation but instead by possible mucosal autoregulatory escape.
评估α1、β1和β2受体激动剂去甲肾上腺素与α1激动剂去氧肾上腺素对心脏手术后空肠黏膜灌注、胃-动脉二氧化碳分压差以及整体内脏氧供需关系的潜在差异影响。
一项随机、前瞻性、介入性交叉研究。
一所大学心胸重症监护病房。
10例患者在单纯冠状动脉搭桥手术后接受丙泊酚镇静和机械通气期间接受研究。
每位患者随机且依次接受去甲肾上腺素(0.052±0.009微克/千克/分钟)和去氧肾上腺素(0.50±0.22微克/千克/分钟),以使平均动脉血压升高30%。
在达到目标平均动脉血压之前(对照)以及在30分钟药物输注期间,获取关于空肠黏膜灌注、空肠黏膜血细胞比容和红细胞速度(激光多普勒血流仪)的数据,以及胃-动脉二氧化碳分压差(张力测定法)和内脏氧摄取的数据。对第二种血管升压药依次重复该操作。两种药物均使全身血管阻力增加40% - 46%,心脏指数无变化。两种血管升压药均未影响空肠黏膜灌注、空肠黏膜血细胞比容、红细胞速度或胃-动脉二氧化碳分压差。去甲肾上腺素使内脏氧摄取从38.2%增加至43.1%(p<0.001),去氧肾上腺素使其从39.3%增加至47.5%(p<0.001)。与去甲肾上腺素相比,去氧肾上腺素引起的这种增加更为显著(p<0.05)。两种药物均使混合静脉-肝静脉血氧饱和度梯度增加(p<0.01),且去氧肾上腺素引起的增加更显著(p<0.05)。两种血管升压药均未显著影响内脏乳酸摄取。
与去甲肾上腺素相比,去氧肾上腺素引起更明显的整体α1介导的内脏血管收缩。两种血管收缩剂均未损害心脏手术后患者的胃肠道黏膜灌注。去甲肾上腺素诱导的α1介导的胃肠道灌注损害的缺乏不能用β2介导的对抗性血管舒张来解释,而可能是由于黏膜自身调节逃逸。